HIGH-DOSE CONSOLIDATION THERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN STAGE-IV BREAST-CANCER

[1] BULL JM, 1978, CANCER, V41, P1649, DOI 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO

[2] 2-J

[3] CHLEBOWSKI RT, 1979, CANCER RES, V39, P4503

[4] HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1592 - 1597

[5] JONES RB, 1988, P AN M AM SOC CLIN, V7, P8

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] MULDER NH, 1988, P AN M AM SOC CLIN, V7, P8

[8] PETERS WP, 1987, P AM ASSOC CANC RES, V28, P227

[9] A COMPARISON OF REFLECTED VERSUS TEST-BASED CONFIDENCE-INTERVALS FOR THE MEDIAN SURVIVAL-TIME, BASED ON CENSORED-DATA [J]. BIOMETRICS, 1984, 40 (03) : 587 - 600

[10] SMALLEY RV, 1977, CANCER, V40, P625, DOI 10.1002/1097-0142(197708)40:2<625::AID-CNCR2820400206>3.0.CO

[1] BULL JM, 1978, CANCER, V41, P1649, DOI 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO

[2] 2-J

[3] CHLEBOWSKI RT, 1979, CANCER RES, V39, P4503

[4] HIGH-DOSE COMBINATION ALKYLATING AGENT CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW SUPPORT FOR METASTATIC BREAST-CANCER [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) : 1592 - 1597

[5] JONES RB, 1988, P AN M AM SOC CLIN, V7, P8

[6] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481

[7] MULDER NH, 1988, P AN M AM SOC CLIN, V7, P8

[8] PETERS WP, 1987, P AM ASSOC CANC RES, V28, P227

[9] A COMPARISON OF REFLECTED VERSUS TEST-BASED CONFIDENCE-INTERVALS FOR THE MEDIAN SURVIVAL-TIME, BASED ON CENSORED-DATA [J]. BIOMETRICS, 1984, 40 (03) : 587 - 600

[10] SMALLEY RV, 1977, CANCER, V40, P625, DOI 10.1002/1097-0142(197708)40:2<625::AID-CNCR2820400206>3.0.CO